Fotovaporización con láser CO2 en condilomatosis genital masculina, a propósito de un caso.

Read full text
Authors: García, Ana, Manrique, Cleicy, Ajakaida, Renaud
Cited by: 0

Abstract

Human papillomavirus (HPV) genital infection is a relatively prevalent sexually transmitted condition, including low-risk subtypes 6 and 11, which are associated with condyloma acuminatum. Carbon dioxide (CO2) laser vaporization therapy has proven to be an effective alternative for condylomatous genital lesions, demonstrating favorable outcomes in wart ablation and a low recurrence rate. This case study aimed to evaluate the effectiveness of CO2 laser photovaporization in the treatment of male genital condylomatosis in a 47-year-old patient with multiple condylomatous lesions on the glans penis, with a 3-month history, leading to difficulties in foreskin retraction; biopsy confirmed genital condylomatosis. A combined therapeutic protocol was implemented, consisting of CO2 laser photovaporization at an intensity of 6 Watts for 3 minutes, administered across six sessions with intervals of 3 weeks, coupled with a circumcision, to achieve the desired aesthetic and functional recovery. Pre-treatment clinical evaluation revealed multiple cauliflower-like lesions with purulent exudate; two months later, the penis exhibited diminished edema, absence of exudate, and a reduction in the area of necrosis, concurrent with complete lesion remission. In conclusion, CO2 laser photovaporization demonstrates effectiveness in the total reduction of penile condyloma-like lesions attributed to HPV. Due to the limitations of these preliminary findings, further investigations with increased sample sizes and varied study designs are needed to fully determine the treatment's efficacy across diverse genital conditions.

Fields of Study & Subjects

Genital Health and Disease Cervical Cancer and HPV Research Female Genital Mutilation/Cutting Issues

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
1 January 2026
Language
ES